Почетна › Рак простате › Висконсин
Kliničke studije za Рак простате u državi Висконсин
47 studija za Рак простате traži učesnike na lokacijama u državi Висконсин.
Gradovi u državi Висконсин
- Madison29 студија
- Milwaukee19 студија
- Stevens Point7 студија
- Wausau7 студија
- Green Bay6 студија
- West Bend5 студија
- Sheboygan5 студија
- Eau Claire5 студија
- Racine4 студија
- Oshkosh4 студија
- Watertown4 студија
- Manitowoc3 студија
- Kenosha3 студија
Zvanični tekst studije (na engleskom)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek
- и још 13
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 13. 11. 2026. · NCT04423211Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 12. 11. 2026. · NCT05691465Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Duluth Clinic Ashland, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- и још 25
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03866382The Vanguard Study: Testing a New Way to Screen for Cancer
- Zablocki Veterans Administration Medical Center, Milwaukee
Тражи се учесникЗдраве особе су добродошле
Узраст од 45 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06995898WATER IV PCa (AS Sub-study)
- Advocate Aurora Research Institute, Sheboygan
Тражи се учесник
Узраст 45 и старији · Мушкарци · Ажурирано 6. 11. 2026. · NCT07650448ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
- University of Wisconsin-Madison, Madison
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Мушкарци · Ажурирано 6. 11. 2026. · NCT06141993Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- и још 50
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Marshfield Medical Center-Marshfield, Marshfield
- Froedtert Menomonee Falls Hospital, Menomonee Falls
- Medical College of Wisconsin, Milwaukee
- и још 2
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06632977Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Froedtert Menomonee Falls Hospital, Menomonee Falls
- и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT07200830Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
- и још 26
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT06931340A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- University Hospital and UW Health Clinics ( Site 0065), Madison
- Medical College of Wisconsin ( Site 0008), Milwaukee
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 30. 10. 2026. · NCT06925737Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Wisconsin Carbone Cancer Center, Madison
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 1
Узраст од 18 до 100 · Мушкарци · Ажурирано 29. 10. 2026. · NCT05519449Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
- и још 36
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 23. 10. 2026. · NCT05946213Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
- University of Wisconsin-Madison, Madison
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Мушкарци · Ажурирано 22. 10. 2026. · NCT04489719A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- University of Wisconsin, Madison
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07103018A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Medical College of Wisconsin ( Site 0020), Milwaukee
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06136650Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06582017Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 3
Узраст од 18 до 100 · Мушкарци · Ажурирано 15. 10. 2026. · NCT06855277This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT07028853Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
- Mayo Clinic Health System-Eau Claire, Eau Claire
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT06325046Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Langlade Hospital and Cancer Center, Antigo
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- Marshfield Medical Center-Marshfield, Marshfield
- и још 14
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 8. 10. 2026. · NCT03678025FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Wisconsin, Carbone Cancer Center, Madison
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Wisconsin Carbone Cancer Center, Madison
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750PET/CT Characterization of Treatment Resistance
- University of Wisconsin, Madison
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 1. 10. 2026. · NCT05647564Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Medical College Of Wisconsin, Milwaukee
Тражи се учесникФаза 2/3
Узраст од 18 до 100 · Мушкарци · Ажурирано 22. 9. 2026. · NCT06780670High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 17. 9. 2026. · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 17. 9. 2026. · NCT04038502MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
- Carbone Cancer Center University of Wisconsin-Madison, Madison
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 15. 9. 2026. · NCT06150417Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- University of Wisconsin, Madison
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 11. 9. 2026. · NCT06056830Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
- Froedtert & the Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 9. 9. 2026. · NCT07226713A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- UW Health Carbone Cancer Center, Madison
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 3. 9. 2026. · NCT07005154COMPASS Study for Metastatic Castration-resistant Prostate Cancer
- University of Wisconsin Carbone Cancer Center, Madison
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Мушкарци · Ажурирано 27. 8. 2026. · NCT07050433A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- University of Wisconsin Carbone Cancer Center-Madison, Madison
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 21. 8. 2026. · NCT06844383Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Froedtert Hospital, Milwaukee
Тражи се учесник
Узраст 65 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT07227077Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 31. 7. 2026. · NCT06613100Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- и још 10
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 7. 2026. · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- University of Wisconsin Carbone Cancer Center, Madison
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 9. 7. 2026. · NCT05413421Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 19 до 110 · Оба пола · Ажурирано 29. 6. 2026. · NCT02012699Using FAPI PET/MRI to Evaluate Prostate Cancer
- University of Wisconsin, Madison
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 6. 2026. · NCT06675357International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of Wisconsin Carbone Cancer Center, Madison
Тражи се учесникОпсервациона студија
Узраст 21 и старији · Мушкарци · Ажурирано 22. 5. 2026. · NCT03151629Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.